Mr. Speaker, almost 1,600 Canadians and petitioners call on the minister to acknowledge the clear promise and potential of psychedelic-assisted psychotherapies as interventions for treatment-resistant PTSD, major depressive disorders, end-of-life anxiety, and substance addiction.
The petitioners note that psychedelic compounds are derived from plant sources. There is no incentive for pharma companies to invest in the developments of these treatments, so robust public funding is required. They call for significant multi-year research funding at hospitals and universities across the country.